HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of the growth of sarcoma 180 ascites cells by combinations of inhibitors of nucleic acid biosynthesis and the cupric chelate of kethoxal bis-(thiosemicarbazone).

AuthorsA C Sartorelli, B A Booth
JournalCancer research (Cancer Res) Vol. 27 Issue 9 Pg. 1614-9 (Sep 1967) ISSN: 0008-5472 [Print] United States
PMID6051275 (Publication Type: Journal Article)
Chemical References
  • Antimetabolites
  • Antineoplastic Agents
  • Chelating Agents
  • Chlorides
  • DNA, Neoplasm
  • Hydrazines
  • RNA, Neoplasm
  • Stearic Acids
  • Thiosemicarbazones
  • Copper
  • Thioguanine
  • Fluorouracil
  • Uracil Mustard
Topics
  • Animals
  • Antimetabolites (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Chelating Agents (therapeutic use)
  • Chlorides (therapeutic use)
  • Copper (therapeutic use)
  • DNA, Neoplasm (biosynthesis)
  • Drug Synergism
  • Female
  • Fluorouracil (therapeutic use)
  • Hydrazines (therapeutic use)
  • Mice
  • Neoplasm Transplantation
  • RNA, Neoplasm (biosynthesis)
  • Sarcoma 180 (drug therapy)
  • Stearic Acids (therapeutic use)
  • Thioguanine (therapeutic use)
  • Thiosemicarbazones (therapeutic use)
  • Uracil Mustard (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: